<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24044794</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>06</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0887</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>109</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2013</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>
<ISOAbbreviation>Radiother Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients.</ArticleTitle>
<Pagination>
<MedlinePgn>100-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2013.08.035</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0167-8140(13)00435-0</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To test the hypothesis that cardiac comorbidity before the start of radiotherapy (RT) is associated with an increased risk of radiation-induced lung toxicity (RILT) in lung cancer patients.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A retrospective analysis was performed of a prospective cohort of 259 patients with locoregional lung cancer treated with definitive radio(chemo)therapy between 2007 and 2011 (ClinicalTrials.gov Identifiers: NCT00572325 and NCT00573040). We defined RILT as dyspnea CTCv.3.0 grade ≥2 within 6 months after RT, and cardiac comorbidity as a recorded treatment of a cardiac pathology at a cardiology department. Univariate and multivariate analyses, as well as external validation, were performed. The model-performance measure was the area under the receiver operating characteristic curve (AUC).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Prior to RT, 75/259 (28.9%) patients had cardiac comorbidity, 44% of whom (33/75) developed RILT. The odds ratio of developing RILT for patients with cardiac comorbidity was 2.58 (p&lt;0.01). The cross-validated AUC of a model with cardiac comorbidity, tumor location, forced expiratory volume in 1s, sequential chemotherapy and pretreatment dyspnea score was 0.72 (p&lt;0.001) on the training set, and 0.67 (p&lt;0.001) on the validation set.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cardiac comorbidity is an important risk factor for developing RILT after definite radio(chemo)therapy of lung cancer patients.</AbstractText>
<CopyrightInformation>Copyright © 2013 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nalbantov</LastName>
<ForeName>Georgi</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology (Maastro Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: georgi.nalbantov@maastro.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kietselaer</LastName>
<ForeName>Bas</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vandecasteele</LastName>
<ForeName>Katrien</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oberije</LastName>
<ForeName>Cary</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Berbee</LastName>
<ForeName>Maaike</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Troost</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dingemans</LastName>
<ForeName>Anne-Marie</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>van Baardwijk</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smits</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dekker</LastName>
<ForeName>André</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bussink</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Ruysscher</LastName>
<ForeName>Dirk</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lievens</LastName>
<ForeName>Yolande</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lambin</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00572325</AccessionNumber>
<AccessionNumber>NCT00573040</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>09</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>Radiother Oncol</MedlineTA>
<NlmUniqueID>8407192</NlmUniqueID>
<ISSNLinking>0167-8140</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000806">Angiotensin-Converting Enzyme Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006331">Heart Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008168">Lung</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011829">Radiation Dosage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011878">Radiotherapy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cardiac comorbidity</Keyword>
<Keyword MajorTopicYN="N">Dyspnea</Keyword>
<Keyword MajorTopicYN="N">Lung cancer</Keyword>
<Keyword MajorTopicYN="N">Radiation-induced lung toxicity</Keyword>
<Keyword MajorTopicYN="N">Radiotherapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>05</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2013</Year>
<Month>08</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>08</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>9</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>9</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24044794</ArticleId>
<ArticleId IdType="pii">S0167-8140(13)00435-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.radonc.2013.08.035</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>